SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : SYNSORB (T.SYB)(SYBBF) CURE FOR CANCER? -- Ignore unavailable to you. Want to Upgrade?


To: Jim Oravetz who wrote (123)8/11/2000 1:00:00 PM
From: Jim Oravetz  Read Replies (1) | Respond to of 164
 
E. Coli: The Good, the Bad and the Fatal

...In three to 20 percent of cases, mostly in the very young and the elderly, a complication called hemolytic-uremic syndrome (HUS) occurs. In HUS, red blood cells are destroyed and the kidneys fail – and the kidneys may lose function permanently. It can be fatal with a death rate as high as 50 percent in the elderly. snip<>

mediconsult.com

Jim